Skip to main content
main-content

Zeitschrift

Current Hematologic Malignancy Reports

Current Hematologic Malignancy Reports OnlineFirst articles

15.06.2018 | Acute Lymphocytic Leukemias (K Ballen and M Keng, Section Editors)

Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy arising from early T cell progenitors. It accounts for approximately 15% of pediatric and 25% of adult ALL cases, and is twice as prevalent in males as in females …

15.06.2018 | T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

Pathogenesis of Enteropathy-Associated T Cell Lymphoma

Enteropathy-associated T cell lymphoma (EATL) is a rare and an aggressive type of peripheral T cell lymphoma (PTCL) derived from small intestinal intraepithelial lymphocytes (IELs), which occurs in individuals with celiac disease [ 1 ]. An …

14.06.2018 | Multiple Myeloma (P Kapoor, Section Editor)

Novel Approaches for the Management of AL Amyloidosis

Systemic amyloidoses encompass a group of diseases defined by the production and deposition of abnormal, misfolded proteins in the extracellular space of tissues and organs. The two most frequent types of amyloidosis are transthyretin …

23.05.2018 | Myeloproliferative Neoplasms (B Stein, Section Editor)

Management of Myelofibrosis-Related Cytopenias

Of the classic Philadelphia chromosome-negative myeloproliferative neoplasms (Ph − MPN, referred to hereafter as MPN), primary myelofibrosis (PMF) is the most genetically complex, and can be characterized by both proliferative and dysplastic …

05.05.2018 | Health Economics (N Khera, Section Editor)

Frailty in Hematologic Malignancy

Aging adults with hematologic malignancy are a growing demographic. The majority of hematologic malignancies are diagnosed in the older adult [ 1 ] Few clinical trials are dedicated to aging adults specifically, resulting in limited data to gauge …

Aktuelle Ausgaben

Über diese Zeitschrift

Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy.

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise